SCHEMBL2707663

SCHEMBL2707663

CC(=O)Oc1ccc(Sc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.71
ELANE P08246 3/20 0.58
LMNA P02545 3/20 0.52
HPGD P15428 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
GAA P10253 3/20 0.51
ALDH1A1 P00352 3/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
RARB P10826 1/20 0.49
RARG P13631 1/20 0.49
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
RXRG P48443 1/20 0.49
KDM4E B2RXH2 2/20 0.47
TSHR P16473 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ESR1 P03372 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40184 0.89 HSD17B10 (0.88) HSD17B10ELANELMNAGAAALDH1A1
SCHEMBL5355347 0.89 LMNA (0.61) HSD17B10ELANELMNAHPGDL3MBTL1
Methane SCHEMBL7956977 0.87 HSD17B10 (0.85) HSD17B10ELANELMNAGAAALDH1A1
SCHEMBL7026750 0.87 HSD17B10 (0.85) HSD17B10ELANELMNAGAAALDH1A1
Hydrochloric Acid SCHEMBL1374059 0.87 HSD17B10 (0.85) HSD17B10ELANELMNAGAAALDH1A1
SCHEMBL3422384 0.85 ELANE (0.61) HSD17B10ELANELMNAHPGDGAA
SCHEMBL11028806 0.85 HSD17B10 (0.81) HSD17B10ELANELMNAGAAALDH1A1
SCHEMBL2733151 0.84 HSD17B10 (0.51) HSD17B10ELANELMNAHPGDL3MBTL1
SCHEMBL2886930 0.83 HSD17B10 (1.00) HSD17B10ELANELMNAGAAALDH1A1
SCHEMBL10455915 0.83 HSD17B10 (0.79) HSD17B10ELANELMNAHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2435462-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS Pfizer Limited (GB) 2012-04-04 EP disclosed
WO-2010136940-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS PFIZER LIMITED (GB) 2010-12-02 WO disclosed
WO-2010136940-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS PFIZER LIMITED (GB) 2010-12-02 WO disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists NR3C1, NR3C2, MC2R HSD17B10 712/4885ELANE 497/4885LMNA 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.